NCT06531499
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06531499
Title A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study (RADIODOSE)
Acronym RADIODOSE
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | GBR | ESP | DEU | CHE

Facility Status City State Zip Country Details
University of California LA Los Angeles California 90095 United States Details
Stanford University Palo Alto California 94304 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
Wash U School of Medicine St Louis Missouri 63110 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
Novartis Investigative Site Cologne North Rhine-Westphalia 50937 Germany Details
Novartis Investigative Site Wuppertal North Rhine-Westphalia 42283 Germany Details
Novartis Investigative Site Aachen 52074 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site München 80377 Germany Details
Novartis Investigative Site Rostock 18057 Germany Details
Novartis Investigative Site Nijmegen 6525 GA Netherlands Details
Novartis Investigative Site Santiago Compostela A Coruna 15706 Spain Details
Novartis Investigative Site Barcelona 08041 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Madrid 28222 Spain Details
Novartis Investigative Site Bellinzona 6500 Switzerland Details
Novartis Investigative Site Bern 3010 Switzerland Details
Novartis Investigative Site Sutton Surrey SM2 5PT United Kingdom Details
Novartis Investigative Site Birmingham West Midlands B15 2TH United Kingdom Details
Novartis Investigative Site Glasgow G12 0YN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field